
|Articles|June 1, 2011
- Pharmaceutical Executive-06-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - June 2011
Emerging Pharma Leaders 2011
Advertisement
Articles in this issue
almost 15 years ago
Educating Physiciansalmost 15 years ago
To Genzyme, Quality Data Depends on Quality Governancealmost 15 years ago
Drugstore Vaccinationsalmost 15 years ago
A Lack of Informationalmost 15 years ago
Getting IT Togetheralmost 15 years ago
The Futuristic Insightalmost 15 years ago
Optimizing your Value with Payersalmost 15 years ago
Managing Product Lifecyclealmost 15 years ago
To Screen or Not to Screen?almost 15 years ago
Start Serious, Become BolderNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff
2
Eli Lilly Enters $7 Billion Agreement to Acquire Kelonia Therapeutics
3
President Trump Signs Executive Order to Accelerate FDA Reviews for Psychedelic Drugs
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Kelonia Therapeutics
5




